C3.ai heads into its June 3 Q1 report with short sellers adding aggressively, options flipping bullish against the current, and a Street largely unconvinced the company can turn the corner.
Short interest is the defining feature of the AI setup right now. At 34.6% of the free float, it is one of the highest readings in the market — and it has climbed roughly 14% over the past month. The latest weekly jump was sharp: shorts added around 3 million shares between Friday May 8 and Monday May 11, pushing the 30-day build to nearly 6 million shares. The ORTEX short score is running at 73.3, near its highest level of the past two weeks, putting the stock in the 4th percentile of the universe for bearish short positioning. Days to cover is 4.4 at official exchange-reported levels. One thing that cuts against a near-term squeeze: borrow is cheap and freely available. Cost to borrow has actually fallen 26% over the past month to just 0.48% APR, and availability in the lending pool is wide — a reading consistent with plenty of room for more shorts to pile in if they choose. The borrow market is far from stressed.
Options positioning, unusually, points in the opposite direction. The put/call ratio dropped sharply to 0.43 on Tuesday, more than two standard deviations below its 20-day average of 0.53 — the most call-heavy reading in months and close to the 52-week low of 0.27. In a stock with 35% short interest, call-heavy options flow is a notable divergence. It can reflect hedging activity by existing shorts rather than fresh bullish conviction, but the signal is stark enough to warrant attention with earnings less than three weeks away.
The analyst community offers little clarity on direction. Three firms weighed in this week (May 13), and none upgraded. Wedbush's Dan Ives reiterated an Outperform at $15 — by far the most bullish target on the board. DA Davidson held its Underperform at $7. Canaccord nudged its target up marginally from $7 to $8. The consensus mean price target of $8.91 is almost exactly where the stock is trading at $8.79, meaning the Street collectively sees almost no upside at current levels. That figure reflects aggressive post-February target cuts: after the most recent earnings print (a -17% day-one reaction), JP Morgan cut to $7 and DA Davidson cut from $13 to $7. The bull case rests on federal momentum — C3.ai has cited 139% year-over-year growth in government bookings and a restructuring plan targeting $135 million in cost savings from the second half of fiscal 2027. The bear case is stark: subscription revenues declining 16% year-over-year, full-year guidance cut by $51 million, and persistent execution issues in North America and Europe.
Insider activity has added a small net negative tone, though not dramatically so. Founder and Executive Chairman Thomas Siebel sold $2.7 million worth of shares on April 13 and a further $1.4 million on April 14. CEO Stephen Ehikian sold just over $430,000 at the end of March. The 90-day net across all insider activity is a positive $16 million in value terms — but that figure is dominated by non-cash award activity, not open-market buying. Notably, director Jim Snabe bought $77,000 worth at $7.73 in late March and sold $80,000 at $8.08 on the same day, a routine tax-management pattern rather than a directional signal.
Close peers also had a rough week. SOUN fell 11.8% and PGY dropped 7.1%, both moving broadly in line with AI's 6.6% weekly decline. Only GREE and QBTS managed to finish higher on the week — the broader AI-adjacent cohort is in retreat alongside the subject. The RSI14 at 45 is neutral, not yet signalling oversold territory despite the recent slide.
The June 3 print is the clearest near-term catalyst. The last earnings call produced a 17% one-day drop and an 8% further decline over the following five days. With short interest at historically extreme levels, abundant borrow availability, and analyst targets clustered just above current levels, the setup heading into that print is tightly coiled — whether bears are vindicated again or call-heavy options flow proves prescient is what to watch.
See the live data behind this article on ORTEX.
Open AI on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
